Dermatology (36 companies · 19 conditions)

Conditions

Atopic Dermatitis 14 Hidradenitis Suppurativa 7 Rare Psoriasis 6 Alopecia Areata 3 Acne 2 Netherton Syndrome 2 Rare Onychomycosis 2 Pemphigus 2 Rare Recessive Dystrophic Epidermolysis Bullosa 2 Rare Androgenetic Alopecia 1 Common Wart 1 Junctional Epidermolysis Bullosa 1 Rare Lichen Planus 1 Lymphatic Malformation 1 Rare Molluscum Contagiosum 1 Peeling Skin Syndrome 1 Rare PIK3CA-Related Overgrowth Spectrum 1 Rare Rosacea 1 Vitiligo 1

Companies

Ticker	Company	Therapeutic areas	In Dermatology	Lead stage	Programs
ABSI	Absci	DermatologyGI/Hepatology+1	1	Phase 1	6
ACRS	Aclaris Therapeutics	DermatologyGI/Hepatology+1 Rare	5	Phase 2	8
ALDX	Aldeyra Therapeutics	DermatologyOncology+1 Rare	1	NDA Submitted	7
ANAB	AnaptysBio	DermatologyGI/Hepatology+2 Rare	1	Approved	6
APGE	Apogee Therapeutics	DermatologyGI/Hepatology+1 Rare	3	Phase 2	9
RCUS	Arcus Biosciences	DermatologyImmunology+1	1	Phase 3	6
ARTV	Artiva Biotherapeutics	DermatologyImmunology+2 Rare	1	Phase 2	14
BCRX	Biocryst Pharmaceuticals	DermatologyImmunology+1 Rare	1	Approved	4
CABA	Cabaletta Bio	DermatologyImmunology+2 Rare	1	Phase 2	8
CLDX	Celldex Therapeutics	DermatologyImmunology+1	1	Phase 3	7
CRVS	Corvus Pharmaceuticals	DermatologyOncology	1	Phase 3	4
ELOX	Eloxx Pharmaceuticals	DermatologyRenal Rare	2	Phase 2	4
ENTA	Enanta Pharmaceuticals	DermatologyImmunology+1	1	Phase 2	6
EVMN	Evommune	DermatologyImmunology+1	2	Phase 2	5
FBRX	Forte Biosciences	DermatologyGI/Hepatology	2	Phase 2	3
FBIO	Fortress Biotech	DermatologyHematology+2 Rare	3	Approved	12
IMCR	Immunocore	DermatologyInfectious Disease+2	1	Approved	11
INMB	Inmune Bio	DermatologyOncology Rare	1	Phase 2	2
KYMR	Kymera Therapeutics	DermatologyRespiratory Rare	2	Phase 2	4
GLUE	Monte Rosa Therapeutics	CardiovascularDermatology+3 Rare	1	Phase 2	7
MLTX	MoonLake Immunotherapeutics	DermatologyImmunology Rare	1	Phase 3	4
NKTR	Nektar Therapeutics	DermatologyImmunology+2	2	Phase 3	11
ORKA	Oruka Therapeutics	DermatologyImmunology Rare	4	Phase 2	7
PTGX	Protagonist Therapeutics	DermatologyHematology+1 Rare	2	Approved	11
TARA	Protara Therapeutics	DermatologyMetabolic+1 Rare	1	Phase 3	3
QTTB	Q32 Bio	Dermatology	1	Phase 2	2
QNRX	Quoin Pharmaceuticals	DermatologyImmunology Rare	2	Phase 2	4
RLAY	Relay Therapeutics	DermatologyOncology Rare	1	NDA Submitted	5
RVPH	Reviva Pharmaceuticals	CardiovascularDermatology+2 Rare	1	Phase 3	10
SGMT	Sagimet Biosciences	DermatologyMetabolic	2	NDA Submitted	3
SYRE	Spyre Therapeutics	DermatologyImmunology Rare	1	Phase 2	12
TTRX	Turn Therapeutics	DermatologyInfectious Disease Rare	3	Phase 2	4
VNDA	Vanda Pharmaceuticals	CardiovascularDermatology+6 Rare	4	Approved	27
VRCA	Verrica Pharmaceuticals	DermatologyOncology	2	Approved	3
ZBIO	Zenas BioPharma	DermatologyImmunology+2 Rare	1	NDA Submitted	11
ZURA	Zura Bio	DermatologyImmunology Rare	2	Phase 2	5